|
|
 |
|
Viewing report
|
|
|
|
A Guide to Business & Regulatory Strategies: Companion Diagnostic Products and Individual Therapies
Drug and Market Development Publishing, June 2006, Pages: 155
A Guide to Business and Regulatory Strategies: Companion Diagnostic Products and Individual Therapies is a unique compilation of historical companion diagnostic products, business models for drug/diagnostic collaborations, education & marketing, intellectual property, regulatory, and reimbursement information for those interested in developing companion diagnostics, as well as stand-alone diagnostics.
The purpose of this report is to cover topics such as personalized medicine, existing products, business models, intellectual property, regulatory, and insurance/reimbursement issues intended to educate and advise the reader.
Product samples
Chapter 2 Introduction
Customers who bought this item also bought
How Overcoming the Challenge of Biomarker Validation Can Pay Off for Drug and Diagnostic Developers
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
DNA Sequencing 2008
RNAi 2008
Biomarkers 2008
Guide to Good Validation Practice, 3rd Edition
Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers
Asia Pacific Markets for Peripheral Vascular Devices (Australia, China, India, South Korea, Taiwan, Rest of Asia Pacific)
How to Get Ahead with Pharmacogenomics
Companion Diagnostics in Personalized Medicine and Cancer Therapy
Cancer Personalized Medicine 2008
Adme/Tox Technologies
|
|
|
|
